5 Biggest Immunotherapy Companies in the World

In this article, we will take a look at the 5 biggest immunotherapy companies in the world. If you want to see more companies in this selection, go to the 15 Biggest Immunotherapy Companies in the World.

5. AstraZeneca PLC (NASDAQ:AZN)

Market Capitalization: $235.11 billion

Number of Hedge Fund Holders: 42

AstraZeneca PLC (NASDAQ:AZN) is a Cambridge, UK-based biopharmaceutical company that has made significant investments in the area of immunotherapy, with several promising developments in the field. The corporation has created several checkpoint inhibitors, including Imfinzi (durvalumab) and tremelimumab, which have been approved for the treatment of several different types of cancer. In Q1 2023, AstraZeneca PLC (NASDAQ:AZN) posted an EPS of $0.96, beating the analysts’ estimates by $0.14. Furthermore, the company recorded revenue of $10.88 billion, surpassing the analysts’ expectations by $319.8 million. AstraZeneca PLC (NASDAQ:AZN) offers an attractive forward dividend yield of 3.26% as of April 28.

Artisan Partners shared its outlook on AstraZeneca PLC (NASDAQ:AZN) in its Q4 2022 investor letter. Here’s what the firm said:

“In health care, an area where we have been very selective this year, we bought a stake in AstraZeneca PLC (NASDAQ:AZN), a pharmaceutical and medical products company, after it presented its phase 3 data for Capivasertib, a potential treatment for certain patients with metastatic breast cancer. The data were very positive, and we believe it further solidifies AstraZeneca as a market leader in breast cancer treatments.”